Ignite Creation Date:
2024-05-06 @ 3:11 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04545710
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-08
First Post:
2020-09-04
Brief Title:
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
Sponsor:
University of California San Diego
Organization:
University of California San Diego
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lung Cancer |
Keywords: